Rabat: The Mohammed VI Foundation for Sciences and Health (FM6SS) has announced a major scientific breakthrough, having successfully reprogrammed human peripheral blood cells into induced pluripotent stem cells (iPS) for the first time in Morocco. This achievement marks a significant milestone in the field of medical research and innovation within the country.

According to Burkina Information Agency, this strategic advancement aims to establish a national platform for cellular reprogramming and differentiation. This platform is intended to support biomedical research, personalized medicine, and innovative therapies. The Foundation emphasized the importance of this success in positioning Morocco as a center for medical research addressing public health challenges.

iPS cells, which can be derived from a simple blood sample, have the unique capabilities of multiplying and differentiating into any cell type in the body. These properties make iPS cells a crucial tool for modeling human diseases, testing the effectiveness and safety of new drugs, developing regenerative therapies for vital tissues, and designing new immunotherapy approaches for cancer treatment.

The use of iPS cells is already being explored in international clinical trials for the treatment of degenerative diseases, retinal disorders, and certain blood pathologies. With this successful reprogramming, currently undergoing validation and scientific characterization, the Foundation positions Morocco as a pioneering player in the fields of biotechnologies and regenerative medicine.